AEE
41
3
ADT
19
2
MSFT
55
-2
SHW
48
-8
ETR
57
2
SE
55
3
RL
72
3
APD
47
13
NOV
45
-4
IPG
52
2
SYF
92
2
UAL
56
-8
PNW
49
5
BEN
48
-4
GRMN
65
6
O
39
2
FLS
55
3
R
67
2
GWW
57
4
DG
24
-4
AEE
41
3
ADT
19
2
MSFT
55
-2
SHW
48
-8
ETR
57
2
SE
55
3
RL
72
3
APD
47
13
NOV
45
-4
IPG
52
2
SYF
92
2
UAL
56
-8
PNW
49
5
BEN
48
-4
GRMN
65
6
O
39
2
FLS
55
3
R
67
2
GWW
57
4
DG
24
-4
Financhill
Back

Blueprint Medicines Stock Predictions

Unlock the Secret to Earning Monthly Income!

Limited spots act swiftly
Buy
55

BPMC
Blueprint Medicines

Last Price:
91.45
Seasonality Move:
11.38%

7 Day Trial

ALL ACCESS PASS

$ 7

MarketBeat Alert: Strong sell signal just issued for these 20 stocks

Go here now to get free instant access to all 20 stocks to sell.

Blueprint Medicines Stock Forecast

  • Over the next 52 weeks, Blueprint Medicines has on average historically risen by 42.5% based on the past 8 years of stock performance.
  • Blueprint Medicines has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Blueprint Medicines Stock Undervalued?
    The current Blueprint Medicines [BPMC] share price is $93.10. The Score for BPMC is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • BPMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Blueprint Medicines Stock Go Up Next Year?

  • Over the next 52 weeks, Blueprint Medicines has on average historically risen by 42.5% based on the past 8 years of stock performance.

Blueprint Medicines Stock Rating

Buy
55
Blueprint Medicines (BPMC) is a Buy

Is Blueprint Medicines overpriced?

  • Blueprint Medicines has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Blueprint Medicines Stock Price History

Is BPMC stock going to rise?

  • The current trend is moderately bullish and BPMC is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
blueprintmedicines.com

52-Week Data

52-Week High:
101.00
52-Week Low:
43.89

Prediction Charts

Market Cap:
5.7B
Price in USD:
93.10
Volume:
622.91K
Beta:
0.86

Technical Analysis

SMA50:
90.76
SMA100:
86.54
SMA200:
70.52
52-Wk Change:
82.37%

Stock Predictions

  • Is Blueprint Medicines stock public?
    Yes, Blueprint Medicines is a publicly traded company.
  • What is the Blueprint Medicines stock quote today?
    The Blueprint Medicines stock price is 93.10 USD today.
  • How to buy Blueprint Medicines stock online?
    You can buy Blueprint Medicines shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-10 88.13 90.49 90.59 84.55
Apr-11 91.47 92.25 92.56 90.44
Apr-12 92.59 87.25 93.00 87.03
Apr-15 87.18 85.20 87.84 84.33
Apr-16 84.51 86.09 88.08 84.44
Apr-17 87.31 88.38 89.69 86.77
Apr-18 87.93 88.89 91.76 86.56
Apr-19 88.45 86.99 89.90 84.62
Apr-22 87.76 90.69 92.66 86.52
Apr-23 90.48 92.33 94.67 89.19
Apr-24 91.78 92.26 93.74 90.43
Apr-25 89.54 90.73 91.46 88.46
Apr-26 92.76 93.00 94.98 90.47
Apr-29 93.52 93.10 94.91 91.12

Blueprint Medicines Earnings

Blueprint Medicines Earnings Report: Per Share Blueprint Medicines Earnings Q1 Q2 Q3 and Q4 last year and next year.

Blueprint Medicines Forecast Revenue Growth

Blueprint Medicines Stock Analysis: Historical quarterly revenues per share for Blueprint Medicines and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $1.00 per share, an increase next quarter of $0.24 per share, an increase this year of $2.91 per share, and an increase next year of $3.17 per share.

* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.